Literature DB >> 19664567

Poor blood pressure control in general practice: in search of explanations.

Robert Nicodème1, Artus Albessard, Jacques Amar, Bernard Chamontin, Thierry Lang.   

Abstract

BACKGROUND: Arterial hypertension is managed mainly by general practitioners. The blood pressure level of most patients treated in a general practice setting is greater than or equal to 140/90 mmHg. AIMS: To understand why a blood pressure level greater than or equal to 140/90 mmHg does not lead to a change of treatment.
METHODS: Over a 2-week period, 479 hypertensive patients were included in a cross-sectional study by 27 general practitioners. Consultation data were collected, as were reasons why patients with a blood pressure level greater than or equal to 140/90 mmHg did not have their treatment changed.
RESULTS: Blood pressure level was greater than or equal to 140/90 mmHg in 58% of patients; treatment was changed in 15% of these individuals. The lack of change in treatment was justified by the physicians as follows: the blood pressure measurements were not considered to be representative (about 30% of cases); the therapeutic result was considered to be satisfactory in the circumstances (about 30% of cases); change was not appropriate given the patient's specific context (the remaining third of cases). The proportion of uncontrolled hypertensive patients whose treatment remained the same was significantly higher among patients with a disease that affected their lifestyle or threatened their life expectancy.
CONCLUSION: The disappointing therapeutic results observed in the management of arterial hypertension do not arise only from poor application of guidelines by general practitioners. Reluctance to rely on blood pressure measurements, a perception that guidelines are revised frequently and are not always clear, and consideration of the general practitioner's activity in the patient's specific context are the main factors involved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19664567     DOI: 10.1016/j.acvd.2009.02.013

Source DB:  PubMed          Journal:  Arch Cardiovasc Dis        ISSN: 1875-2128            Impact factor:   2.340


  8 in total

1.  Prevalence of inadequate blood pressure control among veterans after acute ischemic stroke hospitalization: a retrospective cohort.

Authors:  Christianne L Roumie; Susan Ofner; Joseph S Ross; Greg Arling; Linda S Williams; Diana L Ordin; Dawn M Bravata
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-06-21

2.  Non-steroidal anti-inflammatory drugs (NSAIDs) and hypertension treatment intensification: a population-based cohort study.

Authors:  Jean-Pascal Fournier; Agnès Sommet; Robert Bourrel; Stéphane Oustric; Atul Pathak; Maryse Lapeyre-Mestre; Jean-Louis Montastruc
Journal:  Eur J Clin Pharmacol       Date:  2012-04-15       Impact factor: 2.953

3.  A titrate-to-goal study of switching patients uncontrolled on antihypertensive monotherapy to fixed-dose combinations of amlodipine and olmesartan medoxomil ± hydrochlorothiazide.

Authors:  Matthew R Weir; Willa A Hsueh; Shawna D Nesbitt; Thomas J Littlejohn; Alan Graff; Ali Shojaee; William F Waverczak; Chunlin Qian; Christopher J Jones; Joel M Neutel
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-02-05       Impact factor: 3.738

4.  Impact of ethnic-specific guidelines for anti-hypertensive prescribing in primary care in England: a longitudinal study.

Authors:  Lena Barrera; Craig Leaper; Utz J Pape; Azeem Majeed; Marta Blangiardo; Christopher Millett
Journal:  BMC Health Serv Res       Date:  2014-02-25       Impact factor: 2.655

5.  General practitioners' justifications for therapeutic inertia in cardiovascular prevention: an empirically grounded typology.

Authors:  Jean-Pierre Lebeau; Jean-Sébastien Cadwallader; Hélène Vaillant-Roussel; Denis Pouchain; Virginie Yaouanc; Isabelle Aubin-Auger; Alain Mercier; Emmanuel Rusch; Roy Remmen; Etienne Vermeire; Kristin Hendrickx
Journal:  BMJ Open       Date:  2016-05-13       Impact factor: 2.692

6.  Random measurement error: Why worry? An example of cardiovascular risk factors.

Authors:  Timo B Brakenhoff; Maarten van Smeden; Frank L J Visseren; Rolf H H Groenwold
Journal:  PLoS One       Date:  2018-02-09       Impact factor: 3.240

7.  Patient and physician related factors of adherence to evidence based guidelines in diabetes mellitus type 2, cardiovascular disease and prevention: a cross sectional study.

Authors:  Johanna Fürthauer; Maria Flamm; Andreas Sönnichsen
Journal:  BMC Fam Pract       Date:  2013-04-04       Impact factor: 2.497

8.  Effects of a multifaceted intervention on cardiovascular risk factors in high-risk hypertensive patients: the ESCAPE trial, a pragmatic cluster randomized trial in general practice.

Authors:  Denis Pouchain; Michel Lièvre; Dominique Huas; Jean-Pierre Lebeau; Vincent Renard; Eric Bruckert; Xavier Girerd; Florent Boutitie
Journal:  Trials       Date:  2013-10-01       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.